Mounjaro — the weight loss injection that suppresses appetite
1 injection per week — and appetite naturally decreases. Original Eli Lilly product, FDA and EMA approved. Up to -22.5% weight loss over 72 weeks (SURMOUNT-1, NEJM 2022).
Key takeaway
Мунджаро (Mounjaro) — це тирзепатід від Eli Lilly, подвійний агоніст GLP-1 і GIP рецепторів. За результатами дослідження SURMOUNT-1, учасники втрачали до 22.5% ваги за 72 тижні. Застосовується 1 раз на тиждень у формі підшкірної ін'єкції.
average result for DOZA clients over 5 months
What is Mounjaro (Tirzepatide)?
Tirzepatide · Eli Lilly
Mounjaro is the brand name for tirzepatide, an innovative injectable product by Eli Lilly. Tirzepatide is the world's first dual GLP-1 and GIP receptor agonist, approved by the FDA (2022) and EMA (2023) for weight management and type 2 diabetes treatment.
In the largest clinical trial SURMOUNT-1 (2,539 participants, NEJM 2022) Mounjaro demonstrated up to −22.5% weight loss over 72 weeks — significantly more than semaglutide (Ozempic/Wegovy) at −15%. The dual GLP-1+GIP mechanism reduces appetite, slows gastric emptying, and improves fat metabolism.
Mounjaro is available as a KwikPen pre-filled injection pen in doses of 2.5, 5, 7.5, 10, and 12.5 mg. It is administered subcutaneously once a week. The starting dose is 2.5 mg for the first 4 weeks to allow body adaptation. The product is approved in 84+ countries, including the EU and UK.
💡 Simply put: Mounjaro restores the satiety signal that is often disrupted in people with excess weight. You eat less — not through willpower, but because your body finally "hears" itself properly.
Mounjaro — Key Dates
Eli Lilly begins development of tirzepatide for type 2 diabetes
FDA approved Mounjaro for type 2 diabetes treatment
SURMOUNT-1 published in NEJM: −22.5% weight over 72 weeks — record among approved products
FDA approved Zepbound (same tirzepatide) separately for weight management
EMA approved Mounjaro for the EU market
Mounjaro approved in 84+ countries, including the UK and Japan
Why Not Pills?
Honest comparison of Mounjaro with pills and diets
| Parameter | Pills / diet | Mounjaro |
|---|---|---|
| Average weight loss | 3–8% | −22.5% |
| Appetite impact | Weak or absent | Strong, via 2 receptors |
| Muscle preservation | Often muscle loss | Muscle preserved |
| Effect duration | Only while taking | Changes eating behavior |
| Regulatory approval | Varies | FDA + EMA + 84 countries |
How Mounjaro (Tirzepatide) Works
How tirzepatide affects the body — dual GLP-1 + GIP mechanism
Tirzepatide is the active ingredient in Mounjaro, the first dual GLP-1 and GIP receptor agonist by Eli Lilly. It acts on two satiety hormones at once, which in the SURMOUNT-1 trial delivered up to −22.5% body weight over 72 weeks.
You inject once a week (thin needle — like vitamins, painless)
The brain receives the "I'm full" signal much sooner — you feel satisfied with smaller portions
Appetite decreases — portions reduce naturally, with specialist support.
Mounjaro (tirzepatide) simultaneously targets two receptors: GLP-1 reduces appetite and slows gastric emptying, while GIP improves insulin sensitivity and fat metabolism.
Mounjaro Side Effects — What to Expect in the First Days
Most clients adapt easily — the most common effects are temporary (1–3 days)
Most common — nausea and stool changes
Appears in the first 1–3 days (usually temporary). Most clients have no or minimal symptoms.
Appetite sharply decreased
Most clients consider this the best "side effect." This is exactly the goal.
Mounjaro is better tolerated than Ozempic
In clinical studies: 5–10% of clients experienced discomfort vs 10–15% with Ozempic.
Starting with minimum dose of 2.5 mg
First 4 weeks are for adaptation. The low dose lets the body "warm up." Increase only by specialist decision.
When Mounjaro is not suitable
History of medullary thyroid cancer, MEN 2 syndrome, pregnancy. A DOZA specialist will check before starting — free.
Telegram response within 5 minutes
If something bothers you after the first injection — write to us. The specialist adjusts the protocol individually. No extra charges.
Most common Mounjaro side effects (by frequency):
- Nausea — in about 10% (usually mild, resolves in 1–2 weeks)
- Reduced appetite — common, this is the expected drug effect
- Diarrhea or constipation — less frequent, mainly at dose titration start
- Headache and fatigue — uncommon, resolve with adaptation
Most common Mounjaro (tirzepatide) side effects: mild nausea (in ~10% of clients), reduced appetite, rarely — diarrhea or constipation.
First Month — What to Expect
Realistic expectations for the first month on Mounjaro
Body adaptation
Dose 2.5 mg. Slight nausea possible in first 1–2 days (~10%). Appetite begins to decrease.
Noticeably lower appetite
Portions decrease naturally. Body has adapted — almost no side effects.
First noticeable results
Increase to 5 mg. Average loss −5–8 kg. Clothes fit looser, face looks slimmer.
Full result
Dosage 7.5–15 mg (individual). Weight decreases steadily. Specialist plans the exit.
Is Mounjaro Right for You?
Suitable if
- ☑BMI ≥ 27 or overweight
- ☑Diets and exercise don't give stable results
- ☑Age 18+ (not pregnant / not breastfeeding)
- ☑Calculate your BMI — → BMI Calculator →
- ☑Not sure how many clicks per dose? — Mounjaro clicks calculator →
Not suitable
- ☒Medullary thyroid cancer / MEN-2
- ☒History of pancreatitis
- ☒Allergy to tirzepatide
Mounjaro Available in Two Formats
Choose a convenient option — original Eli Lilly product in both cases
Real Results · DOZA Clients
Three Stories — Three Different Starts
Anastasia
Ukraine
−17 kg
3 months
"In 3 months on Mounjaro minus 17 kg! Effortless. I tried sports and diets, max -5 kg — then everything stopped."
Tatiana S., 52
Kyiv
−22 kg
6 months
"At 52 I didn't believe anything would help. Mounjaro was a discovery. I feel 10 years younger!"
Maksym D.
Kharkiv
−9 kg
2 months
"Switched from Ozempic — the difference is noticeable. -9 kg vs 4 kg on Ozempic over the same period."
Free · Response within 5 minutes
Want the same result? A specialist will select your program personally
2,147+ clients have already started. No obligations.
What the Largest Study Showed
SURMOUNT-1: 2,539 people, 72 weeks, independent scientific panel. Here are the results — unembellished.
| Parameter | Mounjaro | Ozempic |
|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide |
| Mechanism of action | GLP-1 + GIP (dual) | GLP-1 only |
| Average weight loss | -22.5% | -15% |
| Frequency of use | Once/week | Once/week |
| Manufacturer | Eli Lilly | Novo Nordisk |
| FDA approval year | 2022 | 2017 |
📚 📚 Data Sources
- •SURMOUNT-1 (NEJM, 2022)
Main study: 2,539 participants, 72 weeks. Average weight loss −22.5% at 15 mg dose.
- •SURMOUNT-2 / Long-term data (84 weeks)
With the program extended to 84 weeks, participants achieved −26.6% body weight.
- •FDA approval for type 2 diabetes (2022)
First regulatory approval. FDA confirmed the safety and efficacy of tirzepatide.
- •FDA approval for weight management — Zepbound (2023)
The same tirzepatide under the name Zepbound received separate FDA approval for treating obesity in adults with BMI ≥30.
- •EMA approval (European Union)
The European Medicines Agency confirmed the safety and efficacy of Mounjaro for the EU market.
- •American Diabetes Association — comparative dose table (2023)
ADA published official recommendations for switching between Ozempic and Mounjaro.
Convinced? Next step — free consultation
A specialist will select the dosage for your goals. Response within 5 minutes.
Why a DOZA Program Instead of Going Solo?
You can purchase Mounjaro from various sources. Here's what makes DOZA different.
A specialist, not just delivery
Free consultation before start. Specialist personally selects the protocol. 24/7 Telegram support.
UK version by Eli Lilly with verification
We chose the British version of Mounjaro after experience with other markets — the UK has the lowest counterfeit risk.
Cold chain logistics 2–8°C
Delivered in thermoboxes. Breaking the cold chain means the product loses effectiveness.
A protocol, not a one-time purchase
4–8 months from 2.5 mg to goal and gradual exit. Results without a "rebound effect."
2,147+ clients — we know the nuances
Nausea in the first week, plateaus, exit questions — all of this is already addressed in our protocol.
Individual doses — a unique option
Besides full KwikPens — individual doses for precise titration. More flexibility, less cost.
Mounjaro Dosing — Which One to Choose?
Dosing schedule is selected individually by a specialist. The program starts with 2.5 mg for adaptation.
| Dosage | Weeks | Typical result | Who chooses |
|---|---|---|---|
| 2.5 mg | 1–4 | Adaptation | Starting dose for all |
| 5 mg | 5–8 | −5–8% | After adaptation |
| 7.5 mg | 9–12 | −10–15% | Active phase |
| 10 mg | 13–16 | −15–18% | Optimal result |
| 12.5 mg | 17–20 | −18–22% | Maximum effect |
| 15 mg | 21+ | up to −22.5% | As in SURMOUNT-1 |
* Dosage is selected by a DOZA specialist after a free consultation
Questions Almost Everyone Asks
Answers from DOZA specialists — no marketing, only substance
Do I need a doctor's prescription?
No prescription is needed to receive Mounjaro from DOZA. However, we provide a free consultation — the specialist reviews your history and selects the protocol.
How to inject properly?
KwikPen is a simple pen. Remove the cap, press the button, hold for 10 seconds. Full instructions: /mounjaro-instrukciya.
Can it be combined with other medications?
Mounjaro is compatible with most medications. Be sure to inform your specialist if you take insulin, metformin, or anticoagulants.
What to do if I miss an injection?
If you missed less than 4 days — inject immediately. If more than 4 days — skip that dose and continue on schedule.
💬 Ask a DOZA specialist on Telegram →
💬 Ask a Specialist → →How the Program Works
Step-by-step plan from first consultation to results
Free consultation
A specialist evaluates your goals, selects the optimal program and dose. Telegram response within 5 minutes.
Program start · 2.5 mg
Minimum dose for body adaptation. Appetite reduction from the first days. Initial -2 to -4 kg.
Gaining momentum · 5 mg
Dose increase for enhanced effect. Noticeable weight loss. -5 to -8 kg from start.
Optimal result · 7.5-10 mg
Maximum effectiveness. Sustained weight loss of -10 to -15 kg. Specialist adjusts the plan.
Goal achievement and maintenance
Reaching target weight. Building new habits. Exit program to maintain results.
Who Qualifies for Mounjaro
Suitable
- BMI 27+ with comorbidities
- BMI 30+ (overweight)
- Unable to lose weight with diets
- Appetite control issues
- Motivated to change lifestyle
Contraindications
- ✕Pregnancy and breastfeeding
- ✕History of medullary thyroid cancer
- ✕MEN 2 syndrome
- ✕Severe GI conditions
- ✕Allergy to product components
Take the quiz to find out if Mounjaro is right for you
Take the 8-step survey — and get a personalized recommendation for which program and dose is right for you.
* The quiz does not replace a specialist consultation.
Original Mounjaro with Delivery Across Ukraine
How DOZA guarantees product authenticity and safety
Payment
Card, Apple/Google Pay, or cash on delivery
Thermobox
Cold chain 2–8°C from warehouse to door
Delivery 1–2 days
Nova Poshta or courier across Ukraine
Anonymity
Neutral packaging, no product name visible outside
You receive
Mounjaro KwikPen — UK Version by Eli Lilly
Pen-injector with a unique serial number on the package. Verified on the manufacturer's official website in 30 seconds. Delivered in a thermobox at 2–8°C — exactly as the manufacturer requires.
Authenticity verification guide → →Attention: Cold Chain required
Tirzepatide maintains efficacy only at 2–8°C. Every DOZA shipment comes in a certified thermobox with a temperature indicator. Authenticity verification guide → →
DOZA Client Results with Mounjaro
Real results over 1–6 months — unfiltered and unedited
Natalya
Kyiv · 5 months
−18 kg
Mounjaro 10 mg
“Appetite dropped 70% in the first week. I didn't even think it would work like this.”
Dmytro L.
Kyiv
-12 kg
3 months · 7.5 mg
“Sugar cravings disappeared on their own. For the first time in years, no cravings after dinner.”
Tetiana V.
Kharkiv
-8 kg
2 months · 5 mg
DOZA Client Reviews
Dmytro L.
Ukraine · February 2026
-16 kg in 4 months
Mounjaro 7.5 mg
Lost 16 kg. What impressed me most is that you don't need to starve — appetite genuinely decreases. Specialist available 24/7, even answered at 2 AM.
Ksenia
Ukraine · January 2026
-12 kg in 3 months
Mounjaro 10 mg
Measurements dropped very well. Very satisfied with the result! Everything as promised — original Eli Lilly, thermobox delivery.
Olena M.
Dnipro · December 2025
-9 kg in 2 months
Mounjaro 7.5 mg
I saw the first changes after just 10 days. Appetite decreased smoothly, without stressing the body.
Andrii K.
Odesa · March 2026
-21 kg in 5 months
Mounjaro 12.5 mg
From 110 to 89 kg in 5 months. The doctor selected the right protocol and supported me from day one.
Frequently Asked Questions About Mounjaro
Answers to the most popular questions from our clients
Ready to Start the Mounjaro Program?
Free specialist consultation. We'll select the optimal program for your goals.
Telegram response within 5 minutes · No obligations
Scientific Evidence: Why Mounjaro Is More Effective Than Diets
Mounjaro (tirzepatide) — a dual GLP-1 and GIP receptor agonist by Eli Lilly. Tirzepatide is the world's first product targeting two incretin receptors simultaneously, providing: GLP-1 and GIP — appetite reduction, improved insulin sensitivity, and optimized fat metabolism. (SURMOUNT-1, NEJM 2022, 2,539 participants).
SURMOUNT-1 (NEJM, 2022), with — the maximum tirzepatide dose of 15 mg achieved −22.5% weight loss over 72 weeks vs −2.4% in the placebo group..
The FDA approved tirzepatide for obesity treatment in November 2023 (as Zepbound), EMA — in October 2023 (as Mounjaro). Today Mounjaro is available in 84+ countries. View Mounjaro catalog →.
At DOZA you receive original Mounjaro by Eli Lilly (UK version) with full specialist support — from selecting the starting dose to gradual program exit. Learn price →.
GLP-1 Products Comparison
Mounjaro vs Ozempic vs Wegovy vs Saxenda — key differences
| Parameter | Mounjaro | Ozempic | Wegovy | Saxenda |
|---|---|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide 1 mg | Semaglutide 2.4 mg | Liraglutide |
| Mechanism | GLP-1 + GIP | GLP-1 | GLP-1 | GLP-1 |
| Weight loss | -22.5% | -14.9% | -16.9% | -8% |
| Key study | SURMOUNT-1 | SUSTAIN | STEP-1 | SCALE |
| Frequency | 1×/week | 1×/week | 1×/week | Daily |
| Manufacturer | Eli Lilly | Novo Nordisk | Novo Nordisk | Novo Nordisk |
| Available at DOZA | In stock | Inquire | — | — |
Detailed Mounjaro vs Ozempic comparison — on a dedicated page. Data from SURMOUNT-1 (NEJM, 2022), STEP-1 (NEJM, 2021), SCALE (NEJM, 2015).
Chosen your program and ready to start? All KwikPen doses 2.5–15 mg, current prices and checkout — Buy Mounjaro in Ukraine with cold-chain 2–8°C delivery and 24/7 specialist support.
Complete Mounjaro Guide — Related Pages
Buy Mounjaro
All KwikPen dosages and individual doses. Prices, availability.
Mounjaro Instructions
Full KwikPen instructions with photos and video.
Mounjaro Price
Mounjaro program cost in Ukraine.
Mounjaro vs Ozempic
Comparing tirzepatide and semaglutide — which is better?
Mounjaro for Weight Loss
How Mounjaro works for weight management.
Client Results
Before and after photos, real DOZA client reviews.
Mounjaro vs Biopatid
Comparing Mounjaro and Biopatid — 2 DOZA programs.
Retatrutide vs Mounjaro
Triple vs dual agonist — detailed comparison.
Mounjaro or Peptides?
Comparing GLP-1 program with peptide therapy.
Mounjaro Plateau — 7 Strategies
How to overcome a plateau while taking tirzepatide.
Ozempic — Info Hub
Complete Ozempic (semaglutide) guide by DOZA.
Ozempic Catalog
Ozempic dosages and prices in Ukraine.
Ozempic Price
Ozempic cost in Ukraine from DOZA.
Biopatid — Info Hub
Complete Biopatid guide by DOZA.
Retatrutide — Info Hub
Triple GLP-1+GIP+Glucagon agonist by DOZA.
Buy Mounjaro in Kyiv
Taxi delivery 1–2 hr in a 2–8°C thermobox.
Take a free test
2 minIn 2 minutes, find out which program suits you best. Personalized weight loss and cost estimate.
Choose Mounjaro dosage
Original KwikPen pens by Eli Lilly — with delivery and 24/7 specialist support
This information is for educational purposes only and does not constitute medical advertising. We recommend an individual specialist consultation before starting the program. Results may vary depending on individual characteristics. Mounjaro® is a registered trademark of Eli Lilly and Company.